Cargando…

Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection

OBJECTIVE: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. DESIGN: This was an observational, retrospective study based on real-world data...

Descripción completa

Detalles Bibliográficos
Autores principales: McPadden, Jacob, Warner, Frederick, Young, H. Patrick, Hurley, Nathan C., Pulk, Rebecca A., Singh, Avinainder, Durant, Thomas J. S., Gong, Guannan, Desai, Nihar, Haimovich, Adrian, Taylor, Richard Andrew, Gunel, Murat, Dela Cruz, Charles S., Farhadian, Shelli F., Siner, Jonathan, Villanueva, Merceditas, Churchwell, Keith, Hsiao, Allen, Torre, Charles J., Velazquez, Eric J., Herbst, Roy S., Iwasaki, Akiko, Ko, Albert I., Mortazavi, Bobak J., Krumholz, Harlan M., Schulz, Wade L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011821/
https://www.ncbi.nlm.nih.gov/pubmed/33788846
http://dx.doi.org/10.1371/journal.pone.0243291
_version_ 1783673281694400512
author McPadden, Jacob
Warner, Frederick
Young, H. Patrick
Hurley, Nathan C.
Pulk, Rebecca A.
Singh, Avinainder
Durant, Thomas J. S.
Gong, Guannan
Desai, Nihar
Haimovich, Adrian
Taylor, Richard Andrew
Gunel, Murat
Dela Cruz, Charles S.
Farhadian, Shelli F.
Siner, Jonathan
Villanueva, Merceditas
Churchwell, Keith
Hsiao, Allen
Torre, Charles J.
Velazquez, Eric J.
Herbst, Roy S.
Iwasaki, Akiko
Ko, Albert I.
Mortazavi, Bobak J.
Krumholz, Harlan M.
Schulz, Wade L.
author_facet McPadden, Jacob
Warner, Frederick
Young, H. Patrick
Hurley, Nathan C.
Pulk, Rebecca A.
Singh, Avinainder
Durant, Thomas J. S.
Gong, Guannan
Desai, Nihar
Haimovich, Adrian
Taylor, Richard Andrew
Gunel, Murat
Dela Cruz, Charles S.
Farhadian, Shelli F.
Siner, Jonathan
Villanueva, Merceditas
Churchwell, Keith
Hsiao, Allen
Torre, Charles J.
Velazquez, Eric J.
Herbst, Roy S.
Iwasaki, Akiko
Ko, Albert I.
Mortazavi, Bobak J.
Krumholz, Harlan M.
Schulz, Wade L.
author_sort McPadden, Jacob
collection PubMed
description OBJECTIVE: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. DESIGN: This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository. SETTING: Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community and teaching facilities in both urban and suburban areas. POPULATIONS: The study included adult patients who had SARS-CoV-2 testing at YNHH between March 1 and April 30, 2020. MAIN OUTCOME AND PERFORMANCE MEASURES: Primary outcomes were admission and in-hospital mortality for patients with SARS-CoV-2 infection as determined by RT-PCR testing. We also assessed features associated with the need for respiratory support. RESULTS: Of the 28605 patients tested for SARS-CoV-2, 7995 patients (27.9%) had an infection (median age 52.3 years) and 2154 (26.9%) of these had an associated admission (median age 66.2 years). Of admitted patients, 2152 (99.9%) had a discharge disposition at the end of the study period. Of these, 329 (15.3%) required invasive mechanical ventilation and 305 (14.2%) expired. Increased age and male sex were positively associated with admission and in-hospital mortality (median age 80.7 years), while comorbidities had a much weaker association with the risk of admission or mortality. Black race (OR 1.43, 95%CI 1.14–1.78) and Hispanic ethnicity (OR 1.81, 95%CI 1.50–2.18) were identified as risk factors for admission, but, among discharged patients, age-adjusted in-hospital mortality was not significantly different among racial and ethnic groups. CONCLUSIONS: This observational study identified, among people testing positive for SARS-CoV-2 infection, older age and male sex as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection. While minority racial and ethnic groups had increased burden of disease and risk of admission, age-adjusted in-hospital mortality for discharged patients was not significantly different among racial and ethnic groups. Ongoing studies will be needed to continue to evaluate these risks, particularly in the setting of evolving treatment guidelines.
format Online
Article
Text
id pubmed-8011821
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-80118212021-04-07 Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection McPadden, Jacob Warner, Frederick Young, H. Patrick Hurley, Nathan C. Pulk, Rebecca A. Singh, Avinainder Durant, Thomas J. S. Gong, Guannan Desai, Nihar Haimovich, Adrian Taylor, Richard Andrew Gunel, Murat Dela Cruz, Charles S. Farhadian, Shelli F. Siner, Jonathan Villanueva, Merceditas Churchwell, Keith Hsiao, Allen Torre, Charles J. Velazquez, Eric J. Herbst, Roy S. Iwasaki, Akiko Ko, Albert I. Mortazavi, Bobak J. Krumholz, Harlan M. Schulz, Wade L. PLoS One Research Article OBJECTIVE: Severe acute respiratory syndrome virus (SARS-CoV-2) has infected millions of people worldwide. Our goal was to identify risk factors associated with admission and disease severity in patients with SARS-CoV-2. DESIGN: This was an observational, retrospective study based on real-world data for 7,995 patients with SARS-CoV-2 from a clinical data repository. SETTING: Yale New Haven Health (YNHH) is a five-hospital academic health system serving a diverse patient population with community and teaching facilities in both urban and suburban areas. POPULATIONS: The study included adult patients who had SARS-CoV-2 testing at YNHH between March 1 and April 30, 2020. MAIN OUTCOME AND PERFORMANCE MEASURES: Primary outcomes were admission and in-hospital mortality for patients with SARS-CoV-2 infection as determined by RT-PCR testing. We also assessed features associated with the need for respiratory support. RESULTS: Of the 28605 patients tested for SARS-CoV-2, 7995 patients (27.9%) had an infection (median age 52.3 years) and 2154 (26.9%) of these had an associated admission (median age 66.2 years). Of admitted patients, 2152 (99.9%) had a discharge disposition at the end of the study period. Of these, 329 (15.3%) required invasive mechanical ventilation and 305 (14.2%) expired. Increased age and male sex were positively associated with admission and in-hospital mortality (median age 80.7 years), while comorbidities had a much weaker association with the risk of admission or mortality. Black race (OR 1.43, 95%CI 1.14–1.78) and Hispanic ethnicity (OR 1.81, 95%CI 1.50–2.18) were identified as risk factors for admission, but, among discharged patients, age-adjusted in-hospital mortality was not significantly different among racial and ethnic groups. CONCLUSIONS: This observational study identified, among people testing positive for SARS-CoV-2 infection, older age and male sex as the most strongly associated risks for admission and in-hospital mortality in patients with SARS-CoV-2 infection. While minority racial and ethnic groups had increased burden of disease and risk of admission, age-adjusted in-hospital mortality for discharged patients was not significantly different among racial and ethnic groups. Ongoing studies will be needed to continue to evaluate these risks, particularly in the setting of evolving treatment guidelines. Public Library of Science 2021-03-31 /pmc/articles/PMC8011821/ /pubmed/33788846 http://dx.doi.org/10.1371/journal.pone.0243291 Text en © 2021 McPadden et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
McPadden, Jacob
Warner, Frederick
Young, H. Patrick
Hurley, Nathan C.
Pulk, Rebecca A.
Singh, Avinainder
Durant, Thomas J. S.
Gong, Guannan
Desai, Nihar
Haimovich, Adrian
Taylor, Richard Andrew
Gunel, Murat
Dela Cruz, Charles S.
Farhadian, Shelli F.
Siner, Jonathan
Villanueva, Merceditas
Churchwell, Keith
Hsiao, Allen
Torre, Charles J.
Velazquez, Eric J.
Herbst, Roy S.
Iwasaki, Akiko
Ko, Albert I.
Mortazavi, Bobak J.
Krumholz, Harlan M.
Schulz, Wade L.
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
title Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
title_full Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
title_fullStr Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
title_full_unstemmed Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
title_short Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
title_sort clinical characteristics and outcomes for 7,995 patients with sars-cov-2 infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011821/
https://www.ncbi.nlm.nih.gov/pubmed/33788846
http://dx.doi.org/10.1371/journal.pone.0243291
work_keys_str_mv AT mcpaddenjacob clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT warnerfrederick clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT younghpatrick clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT hurleynathanc clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT pulkrebeccaa clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT singhavinainder clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT durantthomasjs clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT gongguannan clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT desainihar clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT haimovichadrian clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT taylorrichardandrew clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT gunelmurat clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT delacruzcharless clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT farhadianshellif clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT sinerjonathan clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT villanuevamerceditas clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT churchwellkeith clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT hsiaoallen clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT torrecharlesj clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT velazquezericj clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT herbstroys clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT iwasakiakiko clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT koalberti clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT mortazavibobakj clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT krumholzharlanm clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection
AT schulzwadel clinicalcharacteristicsandoutcomesfor7995patientswithsarscov2infection